Identification and Validation of a Potential Stemness-Associated Biomarker in Hepatocellular Carcinoma.
Yangyang ZhangRuike ZhangLingxiu ZengHaizhou WangRuyi PengMeng ZhangHailin ZhangZhenwei YangLiping GaoMeng WangJing LiuPublished in: Stem cells international (2022)
BUB1, as a potential stemness-associated biomarker, could serve as a therapeutic CSCs-target and predicted the clinical outcomes of patients with HCC.